Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Therapeutic Discovery

Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells

Sheng Tai, Yin Sun, Nan Liu, Boxiao Ding, Elaine Hsia, Sunita Bhuta, Ryan K. Thor, Robert Damoiseaux, Chaozhao Liang and Jiaoti Huang
Sheng Tai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin Sun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nan Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boxiao Ding
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Hsia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunita Bhuta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan K. Thor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Damoiseaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chaozhao Liang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiaoti Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-11-0954 Published June 2012
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: April 2012 to January 2021

AbstractFull-text HTMLPDF
Total352413661631

Cited By

Article Information

Volume 11, Issue 6, pp. 1320-1331

DOI 
https://doi.org/10.1158/1535-7163.MCT-11-0954
PubMed 
22491797

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received November 23, 2011
  • Revision received March 13, 2012
  • Accepted March 28, 2012
  • Published first April 5, 2012.

Article Versions

  • Previous version (April 5, 2012 - 12:25).
  • Previous version (April 10, 2012 - 07:48).
  • Previous version (April 16, 2012 - 08:56).
  • Previous version (May 23, 2012 - 14:15).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2012 American Association for Cancer Research.

Author Information

  1. Sheng Tai1,2,
  2. Yin Sun2,
  3. Nan Liu2,5,
  4. Boxiao Ding2,
  5. Elaine Hsia2,
  6. Sunita Bhuta2,
  7. Ryan K. Thor2,
  8. Robert Damoiseaux4,
  9. Chaozhao Liang1, and
  10. Jiaoti Huang2,3
  1. Authors' Affiliations: 1Department of Urology and Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China; 2Department of Pathology, 3Jonsson Comprehensive Cancer Center and Broad Center for Regenerative Medicine and Stem Cell Biology; 4Molecular Screening Shared Resource, David Geffen School of Medicine at UCLA, Los Angeles, California; and 5Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China
  1. Corresponding Authors:
    Jiaoti Huang, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., 13-229 CHS, Los Angeles, CA 90095. Phone: 310-267-2264; Fax: 310-794-4161; E-mail: JiaotiHuang{at}mednet.ucla.edu; and Chaozhao Liang, Department of Urology and The Geriatric Institute of Anhui, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Avenue, Hefei, Anhui, China 230022. E-mail: Liang_chaozhao{at}163.com
  1. Note: S. Tai and Y. Sun contributed equally to this work.

View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 11 (6)
June 2012
Volume 11, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells
Sheng Tai, Yin Sun, Nan Liu, Boxiao Ding, Elaine Hsia, Sunita Bhuta, Ryan K. Thor, Robert Damoiseaux, Chaozhao Liang and Jiaoti Huang
Mol Cancer Ther June 1 2012 (11) (6) 1320-1331; DOI: 10.1158/1535-7163.MCT-11-0954

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells
Sheng Tai, Yin Sun, Nan Liu, Boxiao Ding, Elaine Hsia, Sunita Bhuta, Ryan K. Thor, Robert Damoiseaux, Chaozhao Liang and Jiaoti Huang
Mol Cancer Ther June 1 2012 (11) (6) 1320-1331; DOI: 10.1158/1535-7163.MCT-11-0954
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Sorafenib Targets VCP in Hepatocellular Cancer Cells
  • RSK2 as Therapeutic Target for Myeloma
  • Dll4-Fc Suppresses Liver Metastasis of SCLC Cells
Show more Therapeutic Discovery
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement